We found no strong evidence that enzyme-assessed triglycerides, LDLc or glucose concentrations at age 15 were associated with subsequent NAFLD at age 17; HDLc at 15 was inversely associated with NAFLD at 17 and insulin at 15 was positively associated with odds of USS steatosis and elevated ALT at 17 (Figure 8). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.